High population immunity from prior SARS-CoV-2 infections and vaccination, combined with ongoing global surveillance showing only low-to-moderate circulation of Omicron subvariants such as XFG and NB.1.8.1, underpins the 96.2% market-implied probability against a new coronavirus pandemic declaration by WHO in 2026. Current data indicate endemic seasonal waves with stable or declining case and death trends, no variants meeting criteria for increased public health risk, and no evidence of novel coronaviruses achieving sustained human-to-human transmission capable of exponential spread. WHO assessments through mid-2026 classify the overall risk as moderate, consistent with endemic rather than pandemic dynamics. Realistic scenarios that could still shift odds include an undetected zoonotic spillover producing a highly transmissible strain with substantial immune evasion or a rapid surveillance gap allowing early undetected escalation before year-end monitoring updates.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · UpdatedNew Coronavirus Pandemic in 2026?
$23,360 Vol.
$23,360 Vol.
$23,360 Vol.
$23,360 Vol.
The resolution source will be official announcements from the World Health Organization.
Market Opened: Jan 6, 2026, 2:40 PM ET
Resolver
0x65070BE91...The resolution source will be official announcements from the World Health Organization.
Resolver
0x65070BE91...High population immunity from prior SARS-CoV-2 infections and vaccination, combined with ongoing global surveillance showing only low-to-moderate circulation of Omicron subvariants such as XFG and NB.1.8.1, underpins the 96.2% market-implied probability against a new coronavirus pandemic declaration by WHO in 2026. Current data indicate endemic seasonal waves with stable or declining case and death trends, no variants meeting criteria for increased public health risk, and no evidence of novel coronaviruses achieving sustained human-to-human transmission capable of exponential spread. WHO assessments through mid-2026 classify the overall risk as moderate, consistent with endemic rather than pandemic dynamics. Realistic scenarios that could still shift odds include an undetected zoonotic spillover producing a highly transmissible strain with substantial immune evasion or a rapid surveillance gap allowing early undetected escalation before year-end monitoring updates.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · Updated


Beware of external links.
Beware of external links.
Frequently Asked Questions